Annual Shareholders Equity
-$136.21 M
-$119.55 M-717.76%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual stockholders equity is -$136.21 million, with the most recent change of -$119.55 million (-717.76%) on December 31, 2023.
- During the last 3 years, KPTI annual shareholders equity has fallen by -$186.75 million (-369.47%).
- KPTI annual shareholders equity is now -165.87% below its all-time high of $206.79 million, reached on December 31, 2014.
Performance
KPTI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$159.65 M
-$27.51 M-20.82%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly stockholders equity is -$159.65 million, with the most recent change of -$27.51 million (-20.82%) on September 30, 2024.
- Over the past year, KPTI quarterly shareholders equity has dropped by -$27.51 million (-20.82%).
- KPTI quarterly shareholders equity is now -157.94% below its all-time high of $275.52 million, reached on March 31, 2015.
Performance
KPTI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
KPTI Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -717.8% | -20.8% |
| 3 y3 years | -369.5% | -26.7% |
| 5 y5 years | -174.4% | -366.7% |
KPTI Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -717.8% | at low | -858.5% | +5.5% |
| 5 y | 5-year | -369.5% | at low | -196.1% | +5.5% |
| alltime | all time | -165.9% | at low | -157.9% | +5.5% |
Karyopharm Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$159.65 M(+20.8%) |
| Jun 2024 | - | -$132.14 M(-21.8%) |
| Mar 2024 | - | -$168.96 M(+24.0%) |
| Dec 2023 | -$136.21 M(+717.8%) | -$136.21 M(+35.7%) |
| Sep 2023 | - | -$100.40 M(+40.9%) |
| Jun 2023 | - | -$71.25 M(+57.7%) |
| Mar 2023 | - | -$45.17 M(+171.2%) |
| Dec 2022 | -$16.66 M(-79.1%) | -$16.66 M(-88.1%) |
| Sep 2022 | - | -$140.28 M(+20.6%) |
| Jun 2022 | - | -$116.34 M(+40.0%) |
| Mar 2022 | - | -$83.08 M(+4.3%) |
| Dec 2021 | -$79.67 M(-257.6%) | -$79.67 M(-36.8%) |
| Sep 2021 | - | -$125.98 M(+51.5%) |
| Jun 2021 | - | -$83.13 M(+109.7%) |
| Mar 2021 | - | -$39.64 M(-178.4%) |
| Dec 2020 | $50.55 M(+1.6%) | $50.55 M(-39.7%) |
| Sep 2020 | - | $83.77 M(-35.5%) |
| Jun 2020 | - | $129.80 M(-21.9%) |
| Mar 2020 | - | $166.15 M(+233.8%) |
| Dec 2019 | $49.77 M(-72.8%) | $49.77 M(-16.9%) |
| Sep 2019 | - | $59.87 M(-27.4%) |
| Jun 2019 | - | $82.47 M(-32.0%) |
| Mar 2019 | - | $121.28 M(-33.8%) |
| Dec 2018 | $183.17 M | $183.17 M(+7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $171.08 M(-19.9%) |
| Jun 2018 | - | $213.47 M(+123.5%) |
| Mar 2018 | - | $95.53 M(-26.2%) |
| Dec 2017 | $129.46 M(-20.2%) | $129.46 M(-8.3%) |
| Sep 2017 | - | $141.18 M(-15.3%) |
| Jun 2017 | - | $166.71 M(+20.5%) |
| Mar 2017 | - | $138.36 M(-14.7%) |
| Dec 2016 | $162.24 M(-18.2%) | $162.24 M(-2.8%) |
| Sep 2016 | - | $166.93 M(+8.7%) |
| Jun 2016 | - | $153.57 M(-13.3%) |
| Mar 2016 | - | $177.04 M(-10.8%) |
| Dec 2015 | $198.37 M(-4.1%) | $198.37 M(-10.1%) |
| Sep 2015 | - | $220.59 M(-10.8%) |
| Jun 2015 | - | $247.33 M(-10.2%) |
| Mar 2015 | - | $275.52 M(+33.2%) |
| Dec 2014 | $206.79 M(+33.5%) | $206.79 M(-9.2%) |
| Sep 2014 | - | $227.80 M(+73.0%) |
| Jun 2014 | - | $131.68 M(-8.6%) |
| Mar 2014 | - | $144.10 M(-7.0%) |
| Dec 2013 | $154.93 M(-655.8%) | $154.93 M(-424.2%) |
| Sep 2013 | - | -$47.78 M(-179.7%) |
| Jun 2013 | - | $59.94 M(-315.0%) |
| Dec 2012 | -$27.88 M(+120.4%) | -$27.88 M |
| Dec 2011 | -$12.65 M | - |
FAQ
- What is Karyopharm Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual shareholders equity year-on-year change?
- What is Karyopharm Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly shareholders equity year-on-year change?
What is Karyopharm Therapeutics annual stockholders equity?
The current annual shareholders equity of KPTI is -$136.21 M
What is the all time high annual shareholders equity for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual stockholders equity is $206.79 M
What is Karyopharm Therapeutics annual shareholders equity year-on-year change?
Over the past year, KPTI annual stockholders equity has changed by -$119.55 M (-717.76%)
What is Karyopharm Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of KPTI is -$159.65 M
What is the all time high quarterly shareholders equity for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly stockholders equity is $275.52 M
What is Karyopharm Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, KPTI quarterly stockholders equity has changed by -$27.51 M (-20.82%)